Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Find out which no fee credit card offers the best travel points. Make an informed choice for your rewards!
28,170 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Today, bitcoin rips past $82,000 as oil prices slump on de-escalation headlines, fueling a wave of short-covering and...
A new Girl Scouts survey reveals AI is now a regular companion for girls ages 5-13, often seen as a smarter tutor and...
MGK's gains have been propelled by a tight core of five megacaps, a dynamic that boosts returns but also raises risk ...
Tuesday brought a notable rally in Honeywell shares as the company outlined a stand-alone path for Quantinuum. This a...
A rocket-test explosion at Cape Canaveral spared critical launch-pad components, preserving a path back to flight for...
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
Palantir rode the AI wave to big gains, but recent performance has paused. This guide analyzes whether palantir stock...
A decade after The DAO hack drained millions of ETH, the crypto security landscape has matured into a cooperative, mu...
In a volatile market, you can still build lasting wealth with steady, high-yield dividend stocks hold. This article e...
San Francisco-based Framework Ventures closes its fourth fund at $400 million, expanding beyond crypto into frontier ...
Netflix trades near its 52-week low as operating strength clashes with subscriber-growth concerns. A stronger FY26 ca...